Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Labcorp Holdings Inc. LH

Healthcare  —  Diagnostics & Research
309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
S&P 500 Member Dividend Champion (5y) Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Labcorp Holdings Inc. (LH) EV/EBITDA

As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a EV/EBITDA of 14.7×. Over the past ten years it has ranged from 5.1× (July 2021) to 19.2× (January 2024); the current reading is higher than 79% of that period. That is below the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 12.9× (8.10%)
FY2024 14.0× (26.88%)
FY2023 19.2× 58.51%
FY2022 12.1× 44.78%
FY2021 8.4× 35.72%
FY2020 6.2× (42.37%)
FY2019 10.7× 20.76%
FY2018 8.9× (19.81%)
FY2017 11.0× 20.54%
FY2016 9.2× (15.09%)

Quarterly

Period EV/EBITDA Change
Jun 2026 13.6× 3.16%
Mar 2026 13.2× 2.17%
Dec 2025 12.9× (12.19%)
Sep 2025 14.7× (0.79%)
42 more quarters

Against its own ten years

Low 5.1× High 19.2×
Ten-year median 11.2×
Current reading's percentile 79

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
TWST Twist Bioscience Corporation compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. 14.7×
ICLR ICON PLC compare 23.5×
RVTY Revvity Inc. compare 24.5×
MTD Mettler-Toledo International, Inc. compare 24.9×
MEDP Medpace Holdings, Inc. compare 28.0×
CRL Charles River Laboratories International, Inc. compare 29.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LH